For those unsure when Chong vaguely rambles on about Accelerated approval & Ph2/3 registrational trial and what it mean this is what she is talking about in clear picture form.
note the benchmarks categories in diagram 2 and apply that to Azer-cel and it's target patients
not x-promo PTX and especially their ex-CEO Yatomi-Clarke have always been able to present this stuff better than Chong could ever hope to.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.3¢ | $77.54K | 5.965M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 8530815 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 852856 | 11 |
View Market Depth
| Last trade - 10.06am 30/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |